Authors:
BUCHANAN CP
OVRUTSKAYA I
CHEZ MG
LOEFFEL M
HAMMER MS
Citation: Cp. Buchanan et al., REASONS FOR DROPPING OUT OF THE KETOGENIC DIET - BEHAVIORAL NONCOMPLIANCE VERSUS PHYSICAL SIDE-EFFECTS, Annals of neurology, 44(3), 1998, pp. 7-7
Authors:
GOODELL W
CHEZ MG
BUCHANAN CP
HAMMER MS
LOEFFEL MF
Citation: W. Goodell et al., BONE-MARROW SUPPRESSION FROM COPPER DEFICIENCY IN 2 PATIENTS ON THE KETOGENIC DIET, Annals of neurology, 44(3), 1998, pp. 12-12
Authors:
CHEZ MG
LOEFFEL M
BUCHANAN CP
FIELDCHEZ M
Citation: Mg. Chez et al., PULSE HIGH-DOSE STEROIDS AS COMBINATION THERAPY WITH VALPROIC ACID INEPILEPTIC APHASIA PATIENTS WITH PERVASIVE DEVELOPMENTAL DELAY OR AUTISM, Annals of neurology, 44(3), 1998, pp. 18-18
Authors:
BARDENSTEIN R
CHEZ MG
HELFAND BT
BUCHANAN C
ZUCKER M
Citation: R. Bardenstein et al., IMPROVEMENT IN EEG AND CLINICAL FUNCTION IN PERVASIVE DEVELOPMENTAL DELAY (PDD) - EFFECT OF VALPROIC ACID, Neurology, 50(4), 1998, pp. 2004-2004
Authors:
CONNOLLY AM
CHEZ MG
PESTRONK A
ARNOLD S
MEHTA S
BUCHANON K
ZUCKER M
DEUEL RK
Citation: Am. Connolly et al., SERUM AUTOANTIBODIES TO HUMAN TEMPORAL-LOBE CORTEX IN CHILDREN WITH EPILEPSY AND LANGUAGE DYSFUNCTION, Annals of neurology, 42(3), 1997, pp. 6-6
Citation: Mg. Chez et al., VALUE OF 24-HOUR EEG VERSUS ROUTINE EEG IN DETECTING OCCULT EPILEPTICACTIVITY IN CHILDREN WITH PERVASIVE DEVELOPMENTAL DELAY, Annals of neurology, 42(3), 1997, pp. 37-37
Citation: Mg. Chez, CLINICAL SPECTRUM OF PATIENTS REFERRED FOR LANDAU-KLEFFNER SYNDROME PREVIOUSLY DIAGNOSED WITH PERVASIVE DEVELOPMENTAL DELAY OR AUTISM - EEG, HMPAO SPECT, AND STEROID-RESPONSE DATA, Neurology, 46(2), 1996, pp. 2004-2004
Citation: Mg. Chez et al., SUPEROXIDE-DISMUTASE OVER ACTIVITY, EXCESSIVE SELENIUM, AND LOW COPPER IN ACQUIRED EPILEPTIC APHASIA (THE LANDAU-KLEFFNER SYNDROME), Annals of neurology, 38(3), 1995, pp. 544-544
Authors:
CHEZ MG
BOURGEOIS BFD
PIPPENGER CE
KNOWLES WD
Citation: Mg. Chez et al., PHARMACODYNAMIC INTERACTIONS BETWEEN PHENYTOIN AND VALPROATE - INDIVIDUAL AND COMBINED ANTIEPILEPTIC AND NEUROTOXIC ACTIONS IN MICE, Clinical neuropharmacology, 17(1), 1994, pp. 32-37